Denosumab for Bone Density Loss: Benefits vs. Risks

For some patients with degenerative bone disorders, the human monoclonal antibody denosumab can reduce BMD loss and the risk for fractures. Ongoing research is revealing the advantages and risks.

What’s New in Neurodegenerative Disease Research

In 2021, scientists continue to learn about diagnosis, treatment and prevention of neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease.

Is the CAR T-Cell Revolution Here?

A tailor-made oncology treatment, CAR T-cell therapy promises to transform cancer care. But can its potential overcome its problems?

Could a Multi-Cancer Early Detection Blood Test Signal a Seismic Shift for Cancer Screening?

Galleri, a test developed by California-based healthcare company Grail, can detect dozens of types of cancer — most of which currently lack a recommended screening test — with a single blood sample. What could that mean for the way clinicians screen for and treat cancer?

Self-Pay Revenue After the Pandemic

Think patient-friendly to get the best outcomes.